Cannabis Use Disorder Treatment Market Set for Significant Expansion as Global Demand Surges from 2025 to 2035

The global cannabis use disorder treatment market is poised for strong growth, driven by rising cannabis consumption, the legalisation of cannabis for recreational and medicinal use, and increasing awareness of cannabis-related health risks. Valued at approximately USD 1.7 billion in 2025, the market is expected to reach USD 2.7 billion by 2035, growing at a CAGR of 4.7% over the forecast period, according to recent market analysis.

This expansion reflects a growing acknowledgment of cannabis use disorder as a significant public health issue and a corresponding increase in the demand for effective treatment interventions.

Gain Valuable Market Knowledge: Request a Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d3136343935

Rising CUD Cases Fuel Market Momentum

Cannabis use is becoming more widespread due to progressive legalization across North America, Europe, and parts of Asia. However, this rise in use has also led to an increase in cannabis dependency and associated health concerns such as cognitive impairment, anxiety, depression, and withdrawal symptoms. Healthcare systems are responding by investing in dedicated treatment protocols to address these concerns.

Scientific studies linking long-term cannabis use with mental health issues and functional decline are prompting the development of both pharmacological and behavioral therapies. In particular, cognitive behavioral therapy (CBT) remains the most adopted treatment, while promising advancements in pharmacotherapies—including N-acetyl cysteine, cannabidiol (CBD), and others—are under clinical investigation to improve treatment outcomes.

Innovation in Digital Therapeutics and Telemedicine

The digitization of mental health support and addiction care is accelerating. Telemedicine platforms and digital therapeutics (DTx) are enabling patients to access therapy remotely, breaking geographical barriers and reducing stigma. These innovations are playing a pivotal role in expanding access to cannabis addiction counseling, especially in underserved regions.

Furthermore, the integration of addiction treatment into mental health care frameworks is proving effective in addressing co-occurring disorders, driving further growth in the market.

Key Country-Wise Outlook

United States

With widespread legalization and a substantial user base, the U.S. commands the largest share in the cannabis use disorder treatment market. The National Institute on Drug Abuse (NIDA) and other federal agencies are funding extensive studies and pilot programs to improve CUD interventions. Public and private insurance coverage for substance use disorder treatment, including cannabis addiction, is increasing adoption.

• CAGR (2025–2035): 5.1%

United Kingdom

In the UK, mental health services are evolving to tackle increasing cases of cannabis misuse, particularly among young adults. The NHS and private treatment facilities offer CBT and contingency management solutions. Growing interest in drug-assisted treatment presents further growth opportunities.

• CAGR (2025–2035): 4.5%

European Union

Countries like Germany, France, and the Netherlands are witnessing rising cases of CUD despite the regulated use of medical cannabis. Government-funded mental health infrastructure and addiction clinics are enhancing care quality. Pharmaceutical companies are intensifying research on therapies aimed at cannabis withdrawal and relapse prevention.

• CAGR (2025–2035): 4.8%

Japan

Although Japan enforces some of the world’s strictest cannabis laws, international influence is prompting shifts in public discourse. Mental health institutions are initiating early-stage education and treatment frameworks. Academic and clinical research is underway to develop non-addictive neuropharmacological treatments.

• CAGR (2025–2035): 3.9%

South Korea

Cannabis remains illegal in South Korea, yet rising global cannabis exposure—especially among returning travelers—is leading to growing awareness of cannabis-related health concerns. Research institutions are beginning to study the impact of cannabis use among youth, with potential long-term implications for the market.

• CAGR (2025–2035): 4.2%

Increased Market Attention: Delve into Detailed Trends and Analysis with Our Report! https://www.futuremarketinsights.com/reports/cannabis-use-disorder-treatment-market

Market Trends and Drivers

1. Medical and Recreational Legalization: The continued legalization of cannabis in major markets is expanding the base population at risk for CUD, increasing demand for treatment services.
2. Growing Research Investments: Institutions and pharmaceutical firms are investing in drug development and clinical trials for effective CUD treatments.
3. Insurance Support: The growing inclusion of CUD treatments under insurance coverage is increasing affordability and patient access.
4. Integration of Services: The combination of mental health services and addiction recovery programs enhances patient outcomes and reduces relapse rates.

Competitive Outlook

The CUD treatment market is undergoing transformation with a strong emphasis on pharmacological therapies, CBT-based interventions, and digital health applications. Companies are racing to develop FDA-approved medications, online therapy platforms, and comprehensive rehabilitation programs.

Key Players in the Market Include:

• Cipla Limited
• Intas Pharmaceuticals Limited
• Orexo AB
• Allergan plc
• Alkermes plc
• Noramco, Inc.
• Mallinckrodt Plc
• Glenmark Pharmaceuticals Limited
• Dr. Reddy’s Laboratories

These companies are focused on innovating and expanding their addiction treatment portfolios through collaborations, clinical trials, and regional expansion strategies.

Market Segmentation

By Type

• Tobacco/Nicotine and Vaping
• Alcohol
• Marijuana
• Synthetic Cannabinoids
• Others

By Treatment

• Detoxification
• Counselling & Behavioral Therapy
• Medication
• Support Groups

By End User

• Hospitals and Clinics
• Rehabilitation Centers
• Others

By Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube